Danimer Scientific Company Insiders
| DNMR Stock | USD 5.20 0.14 2.77% |
Danimer Scientific employs about 257 people. The company is managed by 20 executives with a total tenure of roughly 50 years, averaging almost 2.0 years of service per executive, having 12.85 employees per reported executive. Discussion of Danimer Scientific's management performance can provide insight into the enterprise performance.
Danimer |
Danimer Scientific Management Team Effectiveness
The company has return on total asset (ROA) of (0.088) % which means that it has lost $0.088 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.459) %, meaning that it created substantial loss on money invested by shareholders. Danimer Scientific's management efficiency ratios could be used to measure how well Danimer Scientific manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/22/2024, Return On Tangible Assets is likely to drop to -0.26. In addition to that, Return On Capital Employed is likely to drop to -0.19. As of 11/22/2024, Total Current Assets is likely to grow to about 185.7 M, while Net Tangible Assets are likely to drop slightly above 265.6 M.As of 11/22/2024, Common Stock Shares Outstanding is likely to drop to about 89.3 M. In addition to that, Net Loss is likely to grow to about (153.7 M)
Danimer Scientific Workforce Comparison
Danimer Scientific is rated below average in number of employees category among its peers. The total workforce of Materials industry is currently estimated at about 150,104. Danimer Scientific adds roughly 257 in number of employees claiming only tiny portion of all equities under Materials industry.
Danimer Scientific Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Danimer Scientific insiders, such as employees or executives, is commonly permitted as long as it does not rely on Danimer Scientific's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Danimer Scientific insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2024-06-01 | 1.8889 | 17 | 9 | 1,922,597 | 152,822 |
| 2024-03-01 | 1.0 | 2 | 2 | 60,240 | 46,440 |
| 2023-12-01 | 0.6667 | 2 | 3 | 100,000 | 66,210 |
| 2023-06-01 | 2.6667 | 8 | 3 | 152,822 | 30,000 |
| 2023-03-01 | 1.2857 | 9 | 7 | 3,719,061 | 127,270 |
| 2022-09-01 | 0.6 | 3 | 5 | 68,888 | 205,327 |
| 2022-06-01 | 4.5 | 18 | 4 | 416,425 | 40,000 |
| 2022-03-01 | 1.0909 | 12 | 11 | 2,838,366 | 331,129 |
| 2021-12-01 | 0.3684 | 7 | 19 | 70,000 | 353,704 |
| 2021-09-01 | 1.7273 | 19 | 11 | 1,631,002 | 5,230,000 |
| 2021-03-01 | 3.0 | 9 | 3 | 3,464,940 | 12,785,000 |
| 2020-12-01 | 8.5714 | 60 | 7 | 47,531,091 | 22,188,930 |
Danimer Scientific Notable Stakeholders
A Danimer Scientific stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Danimer Scientific often face trade-offs trying to please all of them. Danimer Scientific's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Danimer Scientific's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Stephen Croskrey | Chairman of the Board, Chief Executive Officer | Profile | |
| John Dowdy | Chief Financial Officer | Profile | |
| Michael Hajost | Chief Financial Officer | Profile | |
| Michael Smith | Chief Operating Officer | Profile | |
| Richard Altice | Interim Director | Profile | |
| James Palczynski | Investor Officer | Profile | |
| Stuart Pratt | Director | Profile | |
| Stephen Esq | Corporate Officer | Profile | |
| Russ Zukowski | Vice Finance | Profile | |
| Anthony Austin | Chief Officer | Profile | |
| Christy Basco | Independent Director | Profile | |
| Gregory Hunt | Independent Director | Profile | |
| Richard Hendrix | Independent Director | Profile | |
| Philip Calhoun | Independent Director | Profile | |
| John III | Senior Analysis | Profile | |
| Phillip Trump | Chief Science and Technology Officer | Profile | |
| John Amboian | Independent Director | Profile | |
| Deborah McRonald | Chief Officer | Profile | |
| Scott Tuten | Chief Marketing and Sustainability Officer | Profile | |
| Isao Noda | Independent Director | Profile |
About Danimer Scientific Management Performance
The success or failure of an entity such as Danimer Scientific often depends on how effective the management is. Danimer Scientific management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Danimer management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Danimer management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.25) | (0.26) | |
| Return On Capital Employed | (0.18) | (0.19) | |
| Return On Assets | (0.22) | (0.23) | |
| Return On Equity | (0.56) | (0.59) |
Danimer Scientific Workforce Analysis
Traditionally, organizations such as Danimer Scientific use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Danimer Scientific within its industry.Danimer Scientific Manpower Efficiency
Return on Danimer Scientific Manpower
| Revenue Per Employee | 181.6K | |
| Revenue Per Executive | 2.3M | |
| Net Loss Per Employee | 605K | |
| Net Loss Per Executive | 7.8M | |
| Working Capital Per Employee | 359.2K | |
| Working Capital Per Executive | 4.6M |
Additional Tools for Danimer Stock Analysis
When running Danimer Scientific's price analysis, check to measure Danimer Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Danimer Scientific is operating at the current time. Most of Danimer Scientific's value examination focuses on studying past and present price action to predict the probability of Danimer Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Danimer Scientific's price. Additionally, you may evaluate how the addition of Danimer Scientific to your portfolios can decrease your overall portfolio volatility.